Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23andMe to Cut 40% of Its Staff
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on using customers’ DNA data to aid in drug discovery.
23andMe cuts 40% of its workforce and discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
23andMe cuts 40% of its workforce
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to "streamline operations and reduce costs."
Hosted on MSN
19h
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
“We are taking these difficult but necessary actions as we restructure
23andMe
and focus on the long-term success of our ...
CBC.ca
16m
23andMe lays off 40% of its workforce, ends therapeutics division
In a prepared statement,
23andMe
CEO and co-founder
Anne
Wojcicki
said the company was "taking these difficult but ...
20h
on MSN
23andMe’s stock falls after company says there’s substantial doubt it can stay in business
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...
19h
23andMe reports sales decline day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Benzinga.com
1d
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
“We are taking these difficult but necessary actions as we restructure
23andMe
and focus on the long-term success of our ...
Yahoo Finance
9h
Q2 2024 23andMe Holding Co. Earnings Call
Anne
Wojcicki
; Chairman of the Board, President, Chief Executive Officer, Co-Founder;
23andMe
Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer;
23andMe
...
6d
Nila Bala: The risks of sharing your DNA with online companies aren’t a future concern. They’re here now
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback